The Impact of Differential Expression of Extracellular Matrix Metalloproteinase Inducer, Matrix Metalloproteinase-2, Tissue Inhibitor of Matrix Metalloproteinase-2 and PDGF-AA on the Chronicity of Venous Leg Ulcers  by Mwaura, B. et al.
*Correspond
Endovascular
Surgery, Wes
Galway, Irela
E-mail address
1078–5884/00The Impact of Differential Expression of Extracellular Matrix
Metalloproteinase Inducer, Matrix Metalloproteinase-2,
Tissue Inhibitor of Matrix Metalloproteinase-2 and PDGF-AA
on the Chronicity of Venous Leg Ulcers
B. Mwaura,1 B. Mahendran,1 N. Hynes,1 D. Defreitas,1 G. Avalos,1 T. Adegbola,2
M. Adham,2 C.E. Connolly2 and S. Sultan1*Departments of 1Vascular and Endovascular Surgery, and Western Vascular Institute, and 2Pathology,
University College Hospital, Galway, IrelandIntroduction. Alteration in the expression of extracellular matrix metalloproteinase inducer (EMMPRIN), matrix
metalloproteinase-2 (MMP-2), tissue inhibitors of matrix metalloproteinases (TIMP-2) and platelet derived growth factor
(PDGF-AA) may contribute to poor healing in venous leg ulcers.
Aim. The aim of this study is to determine the expression of EMMPRIN, MMP-2, TIMP-2 and PDGF-AA in the ulcer
exudates and perivascular tissue of healing and non-healing chronic venous ulcers.
Patients, materials and methods. Forty patients with chronic venous ulcers were included in this study, with a mean age
of 60 years. Eleven patients were males and 29 were females. All patients had normal ankle brachial index and a venous ulcer
of at least 8 weeks duration.
Immuno-histochemistry using monoclonal antibodies to PDGF-AA, MMP-2, TIMP-2 and EMMPRIN was carried out on
paraffin embedded punch biopsy skin specimens from the ulcer edge. Enzyme linked immunosorbent assay for PDGF, MMP-
2 and TIMP-2 were carried out on wound fluids collected from patients. The ulcer size and character at the initial assessment
and after 8 weeks were assessed to determine the status of ulcer healing.
Results. No significant difference was seen in the expression of TIMP-2, MMP-2 and EMMPRIN between the two groups.
However, in the non-healing group high levels of MMP-2 and low levels of TIMP-2 in the wound fluid suggest a strong
correlation of these two markers in the state of healing. Analysis of wound fluid by ELISA demonstrated high PDGF-AA in
the healing group (pZ0.021). Significantly increased levels of PDGF-AA (p!0001) was noted in the perivascular area on
immuno-histochemistry of healing ulcers. These data suggest that PDGF-AA plays an important role in healing of venous
ulcers.
Conclusion. Non-healing venous ulcers are associated with greater activity MMP-2 activity. The ratio of MMPs to their
inhibitors TIMPs, dictate the rate of healing of the ulcers. PDGF-AA activity is associated with ulcer healing, though the
mechanism is unclear. EMMPRIN expression in chronic venous ulcers probably parallels the chronicity of the condition
rather than propagate it. However, further studies with larger samples are needed.Keywords: Matrix metalloproteinase inducer; Matrix metalloproteinase-2; Tissue inhibitors of matrix metalloproteinases;
Platelet derived growth factor; Venous ulcer.Introduction
Chronic venous leg ulcer is common in the aging
population. Venous disease accounts for 81% of ulcers1
and the prevalence of leg ulcers is 1.03% in patients
aged over 70 years. Ambulatory venous hypertensioning author. Mr Sherif Sultan, Consultant Vascular and
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tern Vascular Institute, University College Hospital,
nd.
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0306 + 05 $35.00/0 q 2005 Elsevier Ltd. All rights reseris caused by superficial and deep venous incompe-
tence and alteration of the skin microcirculation
eventually leads to ulceration. Successful wound
healing depends on a complex interplay of cytokines
and growth factors involving inflammation, cell
proliferation, extracellular matrix deposition and
remodelling.2,3 Matrix metalloproteinases (MMP’s)
are secreted by various cells types (fibroblasts,
leukocytes, keratinocytes) as proenzymes and are
activated by membrane type MMP-s or by serine
proteases. MMP’s have been implicated with excessiveEur J Vasc Endovasc Surg 31, 306–310 (2006)
doi:10.1016/j.ejvs.2005.08.007, available online at http://www.sciencedirect.com onved.
The Impact of Differential Expression 307extracellular matrix degradation in chronic venous
ulcers with the resultant failure of completion of the
healing process. Enhanced proteolytic activity attribu-
table to MMP’s has been demonstrated in venous
ulcers.4Aim
The study was designed to determine the expression
of, EMMPRIN, MMP-2, TIMP-2 and PDGF-AA in the
perivascular and stromal areas of healing and non-
healing venous ulcers. Our aim is to assess the
differential expression of the above factors and
alteration in their pattern in relation to the rate of
healing in a group of patients with venous ulcers.Patients, Materials and Methods
Forty patients attending the venous unit were
recruited into the study. In our department patients
are managed following clinical and duplex ultrasound
examination to assess the patency and competence of
deep and superficial veins. Patients were included
with age greater than 50 years (mean age 60 years),
venous leg ulcer duration of at least 8 weeks and ankle
brachial index greater than 0.9. All patients included in
this study were of CEAP clinical stage 6. Exclusion
criteria included deep venous reflux or history of deep
venous thrombosis, cigarette smoking, history of
chronic renal or liver disease, rheumatoid arthritis or
diabetes and usage of steroids or immuno-suppres-
sion. All patients were treated with Proforew (Smith &
Nephew, UK) graduated compression bandaging for 8
weeks. Ethics approval was obtained from local
authority ethics committee, Western Health Board
and all patients gave their informed consent to
inclusion in this study.
The ulcer size and slough at ulcer base was
recorded at the first visit and the healing state was
assessed at subsequent visit 8 weeks later in relation to
change in size, slough, wound contraction and
presence of granulation tissue. Wounds were regarded
as healing if there was a decrease in the size of the
ulcer (O20% decrease in surface area), decrease in
slough and development of healthy granulation tissue.
Patients were allocated into healing and non healing
groups according to the above criteria.
Specimen collection was carried out at the first visit.
Wound fluid exudates were collected from the non
adherent dressing covering the ulcer using sterile
micro-pipettes and frozen immediately at K80 8C. The
collection was done on wounds, which had beendressed not longer than 36 h prior to clinic attendance.
This was followed by 4 mm punch biopsy of the ulcer
bed adjacent to the ulcer edge under local anaesthetic
and immediate fixation in formalin.
Immunoassay was carried out on the wound fluid
that was thawed and assayed at room temperature as
per the ELISA (R&D) protocol for PDGF-AA, MMP-2
and TIMP-2. The results were calculated after aver-
aging the duplicate readings for each standard, control
and the sample. The optical density was plotted to give
the best-fit curve. A standard curve was generated for
each set of samples assayed. The units of the results
were recorded in nanograms for TIMP-2 and MMP-2
and picograms for PDGF-AA after correction for the
dilution factor.
Immuno-histochemistry was carried out on paraffin
embedded skin biopsy sections taken at the edge of the
ulcer. Sections were initially retrieved from paraffin,
followed by heat induced antigen retrieval with EDTA
and subsequently incubated with monoclonal anti-
bodies to EMMPRIN, MMP-2, PDGF-AA and TIMP-2.
The final step was counterstaining and dehydration of
the sections according to the manufacturer’s instruc-
tions. The histological sections were then graded semi-
quantitatively into negative and positive by the
intensity of staining in the stromal and perivascular
zones, by two pathologists blinded to patient groups.
Statistical analysis was carried out using SPSS
software (SPSS Inc., Chicago, IL, USA). The indepen-
dent samples t test was used for quantitative
continuous data while the chi-square test was used
for nominal data arising from immuno-histochemistry
scores. In both tests, a p value of !0.05 was considered
significant. The descriptors used in the text and figure
and tables are the mean and standard deviation.Results
Of the 40 patients that were recruited for study 11 were
male and 29 female. Twenty ulcers were improving
and 20 had no change or deteriorated.
Immunoassay (ELISA) was performed for TIMP-2,
MMP-2 and PDGF-AA on the wound fluid and the
mean immunoassay for TIMP-2 in the healing group
was 1.36 SD 0.96 ng/ml and 0.83 SD 0.77 ng/ml in the
non-healing group. Assay of MMP-2 showed the mean
values of 117 SD 61 ng/ml and 133 SD 12 ng/ml in the
healing and non-healing groups, respectively. There
was no statistical significance between the two groups
for both TIMP-2 and MMP-2 but a trend was noticed
that higher levels were seen in non-healing ulcers
(Table 1). Interestingly a strong correlation of TIMP-2
and MMP-2 levels was recorded on ELISA analysis inEur J Vasc Endovasc Surg Vol 31, 3 2006
Fig. 1. Box plot showing the Immunoassay for PDGF-AA
levels. Box plot shows median, inter-quartile range and 1.5
times inter-quartile range. Higher values were observed in
the healing group (p!0.021, t-test).
Table 1. Results of ELISA analysis of wound fluid for MMP-2 and
TIMP-2
Mean concentration (ng/ml) MMP-2 TIMP-2
Healing ulcer 117 (SD 61) 1.36 (SD 0.96)
Non healing ulcer 133 (SD 12) 0.83 (SD 0.77)
Levels of MMP-2 and TIMP-2 in wound fluid. No statistically
significant association with wound healing was found.
B. Mwaura et al.308the non-healing group (with the r valueZ0.94 and the
p valueZ0.0001), where the TIMP-2 levels were lower;
there was greater activation of MMP-2.
On immunoassay of the wound fluid PDGF-AA
was present at concentration of 102 SD 16 pg/ml in the
healing group in comparison to 88 SD 12 pg/ml in the
non-healing group of ulcers This difference was
statistically significant. (p!0.021), (Box plot Fig. 1).
On immuno-histochemistry, elevated staining pat-
tern of PDGF-AA was noted in the healing group of
patients compared to the non-healing group. This was
reflected in the significant difference in the expression
of PDGF-AA between the two groups (p!0.0001).Table 2. Immuno-histochemistry analysis summary
EMMPRIN MMP-2
Positive Negative Positive
Healing ulcer 9 9 11
Non healing
ulcer
11 9 17
Two samples inadequate for EMMPRIN and one sample was inadequ
MMP-2 and PDGF-AA analysis by immuno-histochemistry.
Eur J Vasc Endovasc Surg Vol 31, 3 2006Immuno-histochemical staining of TIMP-2 was
negative in both groups of patients. The TIMP-2 levels
were probably too low in the tissues to show any
discernable staining pattern. Perivascular or stromal
staining for expression of MMP-2 by immuno-
histochemistry was successful but did not show a
significant difference between the two groups. Stain-
ing for EMMPRI N did not show significant difference
between the healing and non-healing groups of
patients (Table 2).Discussion
There is no uniform consensus on the exact micro-
circulatory changes in the pathogenesis of venous
ulcers but it has been postulated that venous
hypertension results in perivascular leakage of fibrino-
gen that polymerizes to form perivascular fibrin cuff
which impairs the diffusion of oxygen and nutrients
and thus, lead to ulcer formation.5 Various studies
tried to explain the molecular biology of chronic
venous ulcers such as the fibrin cuff theory,5 the trap
hypothesis6 and the white cell trapping theory7 and
none of these theories completely explains the
mechanism and the chronicity of ulceration and
research into this area is still quite extensive.
Extracellular matrix metalloproteinase inducer
(EMMPRIN) is a membrane bound protein that has
been identified in normal keratinocytes.8 It causes
denovo synthesis of MMP-1, MMP-2 and MMP-3
when exposed to human fibroblasts9 and it may
promote the expression of MMP’s in chronic venous
ulcers. Activation of MMP-2 has been immuno-
localized in the dermal-epidermal junction as well as
in perivascular areas in lipodermatosclerosis.10 EMM-
PRIN enhances turnover of extracellular matrix and
unrestrained MMP activity, as seen by the elevated
expression of EMMPRIN and MMP-2 in the perivas-
cular regions in venous leg ulcers and the intense
expression of EMMPRIN, MMP-2, MT1-MMP and
MT2-MMP in dermal structures of venous leg ulcers.4
Our results in the two groups of patients by immuno-
histochemistry showed no significant difference inPDGF-AA
Negative Positive Negative
8 17 1
3 2 18
ate for PDGF-AA and MMP-2. Summary expressions of EMMPRIN,
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that expression of this membrane bound protein is
seen in chronic ulcers irrespective of the healing state
of the ulcer. This supports the finding by Herouy et al.,4
that its expression is associated with enhanced matrix
turnover that is a feature in chronic ulcers.
Platelet-derived growth factor (PDGF) contained in
human platelets in its AA isoform is present at sites of
injury during the acute phase of the wound repair
response11 and impaired healing states may be
associated with reduced expression of this factor.
PDGF stimulates the secretion of other growth
factors involved in the healing process and the
production of matrix components such as collagen12
and hyaluronic acid.13 At late stages of wound healing
it promotes the contraction of collagen matrices
in vitro14 and stimulates the secretion of collagenase.15
Reduction in the expression of PDGF-AA type
receptor expression has been shown in wounded
skin16 of animal models, suggesting that healing
impaired states may be associated with reduced
expression of this factor. Pierce et al.17 showed up-
regulation of PDGF-AA in capillaries and fibroblasts
of acute and chronic wounds treated with PDGF-BB
but not in non-healing dermal ulcers or normal skin.
Similarly, we found increased levels of PDGF-AA
expression in perivascular areas of healing venous
ulcers and not chronic non-healing wounds. PDGF
plays an important role in wound healing by
stimulating smooth cell migration and angiogenesis18.
The injurious effect of matrix metalloproteinases
and their probable role in the aetiology of venous ulcer
is seen by the increased expression of the messenger
RNA and protein of MMP-2 and TIMP-2 in patients
with lipodermatosclerosis compared to normal con-
trols.10 Their proteolytic activity in the acute and
chronic wound environment has been shown by the
elevated activity of MMP-9 and to a lesser extent of
MMP-2 activity. In addition the levels of matrix
metalloproteinases activity in wound fluid samples
collected in patients with healing venous ulcers were
shown to decrease significantly as healing pro-
gressed.19 Our results did not show any significant
difference in the levels of MMP-2 in the two groups of
patients but the mean level of MMP-2 expression was
higher in the non healing group at 133 SD 12 ng/ml
compared to 117 SD 61 ng/ml in the healing group. As
we only looked at MMP-2 and not other matrix
metalloproteinases it is probable that other matrix
metalloproteinases as described by Woessner et al.,20
may be responsible for the degradation and enhanced
matrix turnover in these patients wounds.
The tissue inhibitors of matrix metalloproteinases
(TIMPs) regulate the proteolytic activity of MMPs byinhibition of activated MMP in a 1:1 non-covalent
binding21 and in normal healing wounds both play an
important role in the remodelling of the wound bed.
Lack of TIMP-2 near the migrating epithelial wound
edges might contribute to uncontrolled activity of
MMP-2 in chronic ulcers.22 When an imbalance
primarily exists between levels of matrix metallopro-
teinases and their inhibitors, MMPs bind their TIMPs
to attenuate their capacity to regulate the proteinase
activity in tissue. Such MMP/TIMP complex is seen in
abundance23 in the wound fluid of pressure ulcers.
Further confirmation of this is seen by the increased
levels activated enzyme and pro-enzyme of MMP-2 in
chronic leg ulcers.24 In our study, the mean level of
TIMP-2 was higher in the healing group than in the
non-healing group as was demonstrated by immu-
noassay. In the non- healing group of patients we
noted a correlation between higher MMP-2 and lower
TIMP-2 levels (p!0.0001), suggesting that non-healing
ulcers have a higher levels of proteinase activity. This
effect was observed in other studies regarding
aberrant wound healing and healing of pressure
ulcers.21,22Conclusion
PDGF-AA activity is associated with ulcer healing,
though the mechanism is unclear. EMMPRIN
expression in chronic venous ulcers probably parallels
the chronicity of the condition rather than propagating
it. However, further studies with larger samples are
needed.
The healing of venous ulcers is dependent on the
activity of MMPs. Non-healing venous ulcers are
associated with greater activity MMP-2. The ratio of
MMPs to their inhibitors TIMPs, dictate the rate of
healing of the ulcers. Whether the ratio of TIMP/MMP
in the wound fluid could indicate the future response
of these ulcers to treatment is a subject of further study.References
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